Skip to main content
SpringerLink
Log in

Osteosarcoma and Its Advancement

  • Chapter
  • First Online:
Therapeutic Approaches in Cancer Treatment

Part of the book series: Cancer Treatment and Research ((CTAR,volume 185))

Abstract

Cancer with its high mortality rate is really hard to treat even in this era. Extensive research work is still required to overcome the threat caused by the disease. Currently, the treatment modality is based on the combination therapy, and diagnostics is dependent upon biopsy results. Once the stage of cancer is clear, the treatment is prescribed. To bring a successful treatment approach of patients with osteosarcoma, it requires multidisciplinary team approach including pediatric, medical and surgical oncologist, surgeons, pathologists, pain management, orthopedic oncologist, endocrinologist, and radiologists. Therefore, cancer treatment is to be performed in specialized hospitals able to provide access to all approaches with multidisciplinary team care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meacham CE, Morrison SJ (2013) Tumour heterogeneity and cancer cell plasticity. Nature 501:328–337. https://doi.org/10.1038/nature12624. (PMID: 24048065)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gupta S (2004) New techniques in image-guided percutaneous biopsy. Cardiovasc Intervent Radiol 27:91–104 PMID: 15259803

    Article  PubMed  Google Scholar 

  3. Fletcher CDM, Unni KK (2002) Pathology and genetics of tumours of soft tissue and bone. In: Mertens F (ed) World Health Organization classification of tumours. IARC Press, Lyon, France

    Google Scholar 

  4. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP (2009) Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases

    Google Scholar 

  5. Stiller CA, Bielack SS, Jundt G et al (2006) Bone tumours in European children and adolescents, 1978–1997. Report form the Automated Childhood Cancer Infromation System project. Eur J Cancer 42:2124–2135

    Google Scholar 

  6. Stiller CA, Craft AW, Corazziari I (2001) Survival of children with bone sarcoma in Europe since 1978: results form the EUROCARE study. Eur J Cancer 37:760–766

    Article  CAS  PubMed  Google Scholar 

  7. Li FP, Fraumeni Jr JF (1969) Soft-tissue sarcomas, breast cancer and other neoplasms. A familial syndrome? Ann Intern Med 71:747–752

    Google Scholar 

  8. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49(1):1–31

    Google Scholar 

  9. Tang N, Song WX, Luo J, Haydon RC, He TC (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466(9):2114–2130 (PubMed: 18563507)

    Article  PubMed  PubMed Central  Google Scholar 

  10. Martin JW, Squire JA, Zielenska M (2012) The genetics of osteosarcoma. Sarcoma 2012:627254 (PubMed: 22685381)

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, Futreal PA, Campbell PJ (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144(1):27–40. (PubMed: 21215367)

    Google Scholar 

  12. Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, Glatfelter AA, Duray PH, Meltzer PS (2005) Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 65(20):9226–9235 [PubMed: 16230383]

    Article  CAS  PubMed  Google Scholar 

  13. Bielack S, Jürgens H, Jundt G et al (2009) Osteosarcoma: the COSS experience. Cancer Treat Res 152:289–308

    Google Scholar 

  14. Huth JF, Eilber FR (1989) Patterns of recurrence after resection of osteosarcoma of the extremity. Strategies for treatment of metastases. Arch Surg 124:122–126

    Google Scholar 

  15. Bacci G, Picci P, Briccoli A, Avella M, Ferrari S, Femino FP et al (1992) Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions). Tumori 78:200–206

    Article  CAS  Google Scholar 

  16. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1.702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776–790

    Google Scholar 

  17. Meyer JS, Nadel HR, Marina N et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 51:163–170

    Google Scholar 

  18. Sundaram M, McGuire MH, Herbold DR (1987) Magnetic resonance imaging of osteosarcoma. Skeletal Radiol 16:23–29

    Article  CAS  PubMed  Google Scholar 

  19. Wuisman P, Enneking WF (1990) Prognosis of patients who have osteosarcoma with skip metastasis. J Bone Joint Surg 72A:60–68

    Article  Google Scholar 

  20. Kager L, Zoubek A, Kastner U et al (2006) Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 24:1535–1541

    Article  PubMed  Google Scholar 

  21. Enneking WF, Soanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120

    Article  Google Scholar 

  22. Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341:342–352

    Article  CAS  PubMed  Google Scholar 

  23. Eilber F, Giuliano A, Eckardt J et al (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5:21–26

    Article  CAS  PubMed  Google Scholar 

  24. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A et al (1993) Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72:3227–3238

    Google Scholar 

  25. Gosheger G, Gebert C, Ahrens H et al (2006) Endoprosthetic reconstrction in 250 patients with sarcoma. Clin Orthop 450:164–171

    Article  PubMed  Google Scholar 

  26. Grimer RJ (2005) Surgical options for children with osteosarcoma. Lancet Oncol 6:85–92

    Article  PubMed  Google Scholar 

  27. Kotz RI, Windhager R, Dominkus M et al (2000) A self-extending pediatric leg implant. Nature 406:143–144

    Article  CAS  PubMed  Google Scholar 

  28. Schwarz R, Bruland O, Cassoni A et al (2009) The role of radiotherapy in osteosarcoma. Cancer Treat Res 152:147–165

    Article  PubMed  Google Scholar 

  29. Ozaki T, Flege S, Kevric M et al (2003) Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 21:334–341

    Article  PubMed  Google Scholar 

  30. Franzius C, Bielack S, Flege S et al (2001) High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma. Nuklearmedizin 40:215–220

    Article  CAS  PubMed  Google Scholar 

  31. Cortes EP, Holland JF, Wang JJ et al (1974) Amputation and adriamycin in primary osteosarcoma. N Engl J Med 291:998–1000

    Article  CAS  PubMed  Google Scholar 

  32. Ochs JJ, Freeman AI, Douglass HO et al (1978) cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62:239–245

    CAS  PubMed  Google Scholar 

  33. Jaffe N, Paed D, Farber S et al (1973) Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer 31:1367–1373

    Article  CAS  PubMed  Google Scholar 

  34. Harris MB, Cantor AB, Goorin AM et al (1995) Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Med Pediatr Oncol 24:87–92

    Article  CAS  PubMed  Google Scholar 

  35. Goorin AM, Schwartzentruber DJ, Devidas M et al (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21:1574–1580

    Google Scholar 

  36. Salzer-Kuntschik M, Brand G, Delling G (1983) Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologie 4:135–141

    CAS  Google Scholar 

  37. Sauerbrey A, Bielack S, Kempf-Bielack B et al (2001) High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCI) as salvage therapy for relapsed osteosarcoma. Bone Marrow Transpl 27:933–937

    Article  CAS  Google Scholar 

  38. Strander H, Bauer HC, Brosjo O et al (1995) Long-term adjuvant interferon treatment of human osteosarcoma: a pilot study. Acta Oncol 34(877–880):36

    Google Scholar 

  39. Marina N, Bielack S, Whelan J et al (2009) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res 152:339–354

    Article  CAS  PubMed  Google Scholar 

  40. Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival: a report from the Children’s Oncology Group. J Clin Oncol 26:633–638

    Article  CAS  PubMed  Google Scholar 

  41. Alvarez O, Freeman A, Bedros A et al (1995) Randomized double-blind crossover ondansetron–dexamethasone versus ondansetron–placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 17:145–150

    Article  CAS  Google Scholar 

  42. Kager L, Zoubek A, Potschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21:2011–2018

    Article  PubMed  Google Scholar 

  43. Carrle D, Bielack SS (2009) Osteosarcoma lung metastases detection and principles of multimodal therapy. Cancer Treat Res 152:165–184

    Article  Google Scholar 

  44. Langer T, Stöhr W, Paulides M et al (2005) Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS). Klin Padiatr 217:176–181

    Google Scholar 

  45. Lipshultz SE, Lipsitz SR, Mone SM et al (1995) Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738–1743

    Article  CAS  PubMed  Google Scholar 

  46. Rossi R, Gödde A, Kleinebrand A et al (1994) Unilateral nephrectomy and cisplatin as risk-factors for ifosfamide-induced nephrotoxicity. analysis of 120 patients. J Clin Oncol 12:159–165

    Google Scholar 

  47. Aung L, Gurlick RG, Shi W et al (2002) Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience. Cancer 95:1728–1734

    Article  PubMed  Google Scholar 

  48. Khanna C, Fan TM, Gorlick R et al (1995) Toward a drug development path that targets metastatic progression in osteosarcoma

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Orthopedic Sports Medicine Center, Al Mana General Hospital, Jubail, Saudi Arabia

    Qazi Basit

  2. Hospital of Dalian Medical University, Dalian, Lionning, China

    Haniyah Saleem Qazi

  3. FCPS General surgery, Newcross Hospital, The Royal Wolverhampton Trust, Wolverhampton, UK

    Shumaila Tanveer

Authors
  1. Qazi Basit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haniyah Saleem Qazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shumaila Tanveer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qazi Basit .

Editor information

Editors and Affiliations

  1. Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan

    Asma Saleem Qazi

  2. Respiratory Medicine, Castle Hill Hospital, Cottingham, UK

    Kanwal Tariq

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Basit, Q., Qazi, H.S., Tanveer, S. (2023). Osteosarcoma and Its Advancement. In: Qazi, A.S., Tariq, K. (eds) Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research, vol 185. Springer, Cham. https://doi.org/10.1007/978-3-031-27156-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-27156-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-27155-7

  • Online ISBN: 978-3-031-27156-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation